10.00EUR+0.10%Mkt Cap: 125.17M EURP/E: —Last update: 2026-05-14
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use i…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)4.91
PEG0.07
P/B0.47
P/S0.16
EV/EBITDA9.66
EV/Revenue0.56
EPS (TTM)-8.91
EPS (Forward)2.02
Cash Flow & Leverage
FCF Yield59.30%
FCF Margin9.29%
Operating CF81.09M EUR
CapEx (TTM)36.61M EUR
Net Debt/EBITDA7.08
Net Debt325.70M EUR
Technical
SMA 5010.10 (-1.0%)
SMA 20014.31 (-30.1%)
Beta0.99
S&P 52W Chg24.23%
Avg Vol (30d)15.11K
Avg Vol (10d)10.97K
Technical Indicators
RSI (14)42.9
MACD-0.0139
MACD Signal0.1200
MACD Hist.-0.1338
BB Upper12.27 EUR
BB Middle10.67 EUR
BB Lower9.067 EUR
BB Width30.03%
ATR (14)0.4548 EUR
Vol Ratio (20d)0.62x
52W Range
8.01013% of range23.70
52W High23.70 EUR
52W Low8.010 EUR
Profitability
Gross Margin70.89%
EBITDA Margin5.76%
Profit Margin-13.56%
Oper. Margin-1.70%
ROE-40.57%
ROA-11.65%
Revenue Growth-5.20%
Earnings Growth—
Balance Sheet
Debt/Equity1.65
Current Ratio2.49
Quick Ratio1.08
Book Value/Sh21.16 EUR
Cash/Share9.158 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield2.65%
Payout Ratio0.00%
Ex-Div DateJul 1, 2024
Pay Date—
Splits
Last Split4:1
Split DateJan 23, 2014
Ownership
Shares Out.12.61M
Float5.26M
Insiders63.21%
Institutions7.89%
Analyst Consensus
Rating—
Target (Mean)11.68 EUR
Target Range9.000 EUR – 13.80 EUR
# Analysts4
Company
Market Cap125.17M EUR
Enterprise Value444.05M EUR
Revenue (TTM)798.67M EUR
Gross Profit566.19M EUR
Net Income (TTM)-108.33M EUR
Revenue/Share63.31 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.7K
Last Price10.00 EUR
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN—